Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

/p>

The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials.

Cinryze is for intravenous use only. Per the U.S. label, a dose of 1000 Units of Cinryze can be administered every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered at an injection rate of 1 mL per minute.

About Hereditary Angioedema (HAE)

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States and approximately similar demographics in the European Union.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org or the HAEi (International Patient Organization for C1 Inhibitor Deficiencies) at www.haei.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, 2014 ... ;  Sorrento), an oncology company developing new treatments ... a privately-held immuno-oncology company developing proprietary Neukoplast ® ... therapy, announced today that the companies have entered ... generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for the ...
(Date:12/19/2014)... 18, 2014 Somewhere between dropping five pounds ... forgotten. But Audicus , a next-generation hearing aids ... new year. Hearing loss is the third ... though it is often unaddressed. Forty-eight million Americans have ... hearing aid, mainly due to price. Hearing aids traditionally ...
(Date:12/19/2014)... Dec. 18, 2014  Sage Analytics ( www.sageanalytics.com ... equipment for the testing of marijuana potency and ... new Luminary™ Profiler, the industry,s first product suite ... a cost-effective, portable unit. Designed from ... of the cannabis industry, the Luminary™ Profiler utilizes ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Audicus Will Help People Resolve to Hear Better in 2015 2Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... Science, public health, and regulatory highlights for ... nformation in this document is designed for credentialed journalists. ... April 18, 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... any regulatory or enforcement actions due to legal limitations. ...
... (Nasdaq: LMNX ) today announced that it expects ... Monday, May 9, 2011. A press release announcing the results ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the first quarter ended March 31, 2011, ...
Cached Medicine Technology:FDA News & Notes - Week of April 18, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 3
(Date:12/22/2014)... The MedTech industry is gearing up for new ... of PartnerTech AB of Sweden, is prepared to facilitate the ... Certification. , All signs point to growth in the MedTech ... a repeal of the excise tax originally levied to fund ... annual growth of 9.3% and PartnerTech Inc. is prepared to ...
(Date:12/22/2014)... 7,178 small business owners and marketing professionals ... and opted instead to join Digital Marketer, an Austin, ... 5th annual “Black Friday Boot Camp”. , ... the 5 hour online training event and raised $50,000 ... two Central Texas based charities dedicated to fighting childhood ...
(Date:12/22/2014)... 22, 2014 Christmas is days away, and ... fast and easy solution that will please: the Sublime ... purchased from from $25 up to $350," says Kathy Heshelow, ... satisfaction and a wide array of skin care products and ... no expiration dates. , Gift delivery past shipping deadlines, ...
(Date:12/22/2014)... A substantial percentage of patients ... (CT) to evaluate abnormal findings on outpatient chest ... to a new study published online in the ... show that radiologist recommendations for additional imaging (RAIs) ... care. , RAIs, which have grown 200 percent ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Parker & ... absolute best in Arizona home contracting services reports a ... to its quality services in 2014. As a company ... the early 1970s, Parker and Sons is a business ... The company works side-by-side with other top quality companies ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3
... Mich. Can a grape-enriched diet prevent the downhill sequence ... , A University of Michigan Cardiovascular Center study suggests grapes ... impact that can come from a diet rich in fruits ... phytochemicals naturally occurring antioxidants turning on a protective ...
... Sabertec , an emerging environmental technology company ... designed to reduce CO2 emissions and toxic particulate ... efficiency, took part in a press conference on Tuesday, April ... Harrington .At the press conference, the mayor announced that ...
... Early Detection and Treatment of Lyme is ImperativeNEW YORK, April ... charity dedicated to Lyme disease research and healthcare provider education, ... New York Stock Exchange closing bell on April 23, 2009. ... to the start of LDAM to reinforce the importance of ...
... of the uninsured , , WEDNESDAY, April 22 (HealthDay News) -- ... period of time is greater today than it was two ... in coverage, however, are shorter than they used to be ... Medicaid. , "The bad news is the continuing reduction of ...
... Va., April 22 The National Alliance on Mental ... www.nami.org/soloist , as part of a social ... 24) of The Soloist, starring Jamie Foxx and Robert ... with schizophrenia and are homeless," said NAMI executive director ...
... Halo Pharmaceutical, this week announced that it ... The Provident Bank to expand its operations.Headquartered ... full-service, specialty pharmaceutical company. Halo provides state-of-the-art ... laboratory services to the pharmaceutical and related ...
Cached Medicine News:Health News:Benefit of grapes may be more than skin deep 2Health News:Benefit of grapes may be more than skin deep 3Health News:Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money 2Health News:Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money 3Health News:Turn the Corner Foundation Rings in Lyme Disease Awareness Month Early at NYSE on April 23, 2009 2Health News:Turn the Corner Foundation Rings in Lyme Disease Awareness Month Early at NYSE on April 23, 2009 3Health News:Turn the Corner Foundation Rings in Lyme Disease Awareness Month Early at NYSE on April 23, 2009 4Health News:More Americans Experiencing Gaps in Health Coverage 2Health News:More Americans Experiencing Gaps in Health Coverage 3Health News:The Soloist: A Call to Action 2Health News:Halo Pharmaceutical Completes $14.6 Million in Financing from The Provident Bank 2
... is the first truely web-based solution on the ... POC (managed from the lab) and Critical Care ... of AegisPOC ensures that all groups have the ... in the manner best suited to them. Through ...
... ultrasonic technology. When managing glaucoma patients and ... to use the best technology available. ... analog and digital technology that utilizes ultrasound ... other ultrasonic pachymeters in the market. This ...
...
...
Medicine Products: